Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: Relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 4, 2001, Pages 369-376

  Everett, Simon M ^a   Singh, Raj ^c   Leuratti, Chiara ^c   White, Kay L M ^a   Neville, Peter ^a   Greenwood, Darren ^b   Marnett, Lawrence J ^d   Schorah, Christopher J ^a   Forman, David ^b   Shuker, David ^c   Axon, Anthony T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DEOXYGUANOSINE; MALONALDEHYDE; NONSTEROID ANTIINFLAMMATORY AGENT; THIOBARBITURIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CONTROLLED STUDY; DRUG USE; ENDOSCOPY; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STOMACH JUICE; STOMACH MUCOSA; STOMACH PH;

ADULT; AGED; ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; ENDOSCOPY; FEMALE; GASTRIC JUICE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HUMANS; IMMUNOASSAY; LIPID PEROXIDATION; MALE; MIDDLE AGED;

EID: 0034899119     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
2. Helicobacter pylori infection and the risk of gastric carcinoma
3. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
4. Development of Helicobacter pylori induced gastric carcinoma in Mongolian gerbils
5. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo
6. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems
7. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: Relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication
8. Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection
9. Ascorbic acid in the human stomach
10. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid
11. Unequivocal demonstration that malondialdehyde is a mutagen
12. DNA adducts of α,β-unsaturated aldehydes, and dicarbonyl compounds
13. Mutagenicity of malondialdehyde, a decomposition product of peroxidised polyunsaturated fatty acids
14. Toxicology and carcinogenesis studies of malondialdehyde sodium salt (3-hydroxy-2-propenal, sodium salt) in F344/N rats and B6C3F1 mice
15. Induction of mutations by replication of malondialdehyde-modified M 13 DNA in Escherichia coli: Determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced
16. Serum antioxidant vitamin levels and lipid peroxidation in gastric carcinoma patients
17. Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde
18. Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay
19. Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver
20. 32P-Postlabelling determination of DNA adducts of malondialdehyde in humans: Total white blood cells and breast tissue
21. 32P-postlabelling of malondialdehyde-deoxyguanosine monophosphate in human blood and tissue DNA in relation to diet and H. pylori infection
22. Lipid peroxidation induced putative malondialdehyde-DNA adducts in human breast tissues
23. Development of monoclonal antibodies to the malondialdehyde-deoxyguanosine adduct, pyrimidopurinone
24. A sensitive immunoslot-blot assay for detection of malondialdehyde-deoxyguanosine in human DNA
25. Classification and grading of gastritis. The updated Sydney system
26. 13C-urea breath test for the detection of Helicobacter pylori
27. A simple fluorimetric assay for lipoperoxide in blood plasma
28. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid, and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach
29. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: Effects of gastritis and oral supplementation
30. H. pylori is associated with reduced plasma ascorbic acid concentrations
31. Exocyclic adducts as new risk markers for DNA damage in man
32. Generation of mutagens during arachidonic acid metabolism
33. Chemistry and biology of DNA damage by malondialdehyde
34. Indirect mutagenesis by oxidative DNA damage: Formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal
35. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals
36. Lipid peroxidation and cancer
37. Helicobacter pylori-associated gastric pro- and antioxidant formation in Mongolian gerbils
38. Increased mucosal antioxidant enzyme activities in chronic gastritis and benign gastric polyps
39. Vitamin E and carotenoids in gastric biopsies: The relation to plasma concentrations in patients with and without Helicobacter pylori gastritis
40. DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis
41. Oxidative DNA damage accumulation in gastric carcinogenesis
42. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa
43. Helicobacter pylori infection and urinary excretion of 8-hydroxy-2deoxyguanosine, an oxidative DNA adduct
44. The detection of alkylation damage in the DNA of human gastrointestinal tissues
45. 6-alkylguanine-DNA-alkyltransferase activities in gastric mucosa and circulating lymphocytes
46. 6-Methylguanine in blood leucocyte DNA: An association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis
47. 32P-postlabelling in normal and pre-malignant gastric mucosa
48. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
49. The effect of Helicobacter pylori eradication on DNA single strand breaks in gastric epithelial cells
50. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy
51. Increased gastric epithelial cell proliferation in Helicobacter pylori associated follicular gastritis